Biomarker driven precision oncology therapeutics (liquid and solid tumors) spanning pre-clinical and translational research, clinical development, GMP manufacturing, regulatory approvals and commercialization with cell therapy and immuno-oncology specialty. Expertise in diseases of the spine and pain prevention / management.
Chief Operating Officer at Galen Therapeutics
MS, Biotechnology & Bioinformatics